On Oct. 10, the FDA classified the recalled prescription medication as a Class II recall. The risk classification from the federal agency indicates that the recalled medications could cause "temporary ...

Several lots of the cholesterol medication atorvastatin were recalled after failed dissolution tests, according to the FDA.

More than 140,000 bottles of a popular drug commonly prescribed to reduce cholesterol have been recalled for a defect that ...

Both generic atorvastatin and brand-name Lipitor contain the same active ingredient — atorvastatin calcium — and are considered bioequivalent by the US Food and Drug Administration (FDA). The drug is ...

Efficacy of switching statin therapy from generic simvastatin was examined in a VA population. Ezetimibe/simvastatin was more potent than atorvastatin or rosuvastatin in lowering LDL. Treatment of ...

Cholesterol disorders affect millions of people globally and are among the leading risk factors for cardiovascular diseases, including heart attack and stroke. Statins are the first-line therapy for ...

The erroneous findings emerged from data taken from a large managed-care-organization group of patients who had taken either atorvastatin or simvastatin. Within this cohort of approximately 80 000 ...

High doses of the cholesterol-lowering drug Lipitor were no better at preventing major heart problems than regular doses of rival Zocor, according to the latest study on efforts to aggressively treat ...

The FDA said Ranbaxy has agreed to stop manufacturing Atorvastatin. Nov. 30, 2012 — -- Ranbaxy Pharmaceuticals Inc., the company that makes a generic version of the cholesterol-controlling ...